Results
2
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
2 companies
Nexstim
Market Cap: €93.4m
A medical technology company, engages in the development of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally.
NXTMH
€13.00
7D
-0.4%
1Y
247.6%
Revenio Group Oyj
Market Cap: €622.5m
Provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally.
REG1V
€23.40
7D
-1.9%
1Y
-30.4%